Barclays raised the firm’s price target on American Tower (AMT) to $250 from $246 and keeps an Overweight rating on the shares. The tower stocks have been under pressure since the Q2 results, which were generally positive but faced high expectations and crowded positioning, the analyst tells investors in a research note. The firm remains constructive on the sector, citing a steady spectrum deployment from customers and “recession resilience” should macro conditions deteriorate.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMT:
- Peloton, American Tower, Marathon, Teradyne, eBay: Trending by Analysts
- American Tower price target lowered to $245 from $250 at BMO Capital
- American Tower price target lowered to $250 from $251 at Raymond James
- American Tower price target raised to $255 from $250 at JPMorgan
- HSBC downgrades American Tower on valuation after Q2 report